Anke Klippel-Giese

Title: Anke Klippel-Giese: Innovator in Pharmaceutical Research

Introduction

Anke Klippel-Giese is a notable inventor based in Princeton, NJ (US). She has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds for medical applications. Her work focuses on the modulation of phosphoinositide 3-kinase (PI3K), which plays a crucial role in various diseases.

Latest Patents

Anke Klippel-Giese holds a patent for "Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease." This patent describes compounds of Formula (I) as allosteric chromenone inhibitors of PI3K, which are useful in treating diseases associated with PI3K modulation. The patent includes various forms of the compounds, such as prodrugs, solvates, enantiomers, stereoisomers, tautomers, or pharmaceutically acceptable salts.

Career Highlights

Throughout her career, Anke has worked with prominent companies in the pharmaceutical industry. She has been associated with Petra Pharma Corporation and Silence Therapeutics GmbH, where she has contributed her expertise in drug development and research.

Collaborations

Anke has collaborated with several professionals in her field, including Erin Danielle Anderson and Sean Douglas Aronow. These collaborations have further enhanced her research and innovation in pharmaceutical sciences.

Conclusion

Anke Klippel-Giese is a pioneering inventor whose work in developing allosteric chromenone inhibitors has the potential to impact the treatment of diseases linked to PI3K modulation. Her contributions to the pharmaceutical industry highlight the importance of innovation in medical research.